The Single Use Industry Market comprises the biopharmaceutical manufacturing sector focused on disposable, pre-sterilized processing systems and equipment designed to replace traditional reusable stainless-steel systems for one-time production runs.
The global single-use bioprocessing market was valued at USD 16.51 billion in 2024 and USD 18.01 billion in 2025, and it is projected to reach USD 33.67 billion by 2030, growing at a compound annual growth rate (CAGR) of 13.3%.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297
The single-use industry market in biopharma manufacturing is primarily driven by the growing demand for biologics and vaccines, faster time-to-market enabled by reduced setup and validation times, and cost-effectiveness from lower capital expenses and reduced cross-contamination risks. However, market expansion is heavily restrained by the stringent demands and high cost of high-end manufacturing, alongside persistent concerns regarding extractables and leachables from disposable components that pose risks to product quality and compliance. Lucrative opportunities exist in the untapped market potential of emerging economies like China and India, the rising demand for biosimilars, and recent technological advancements in large-scale single-use bioreactors. Despite these prospects, the market faces key challenges, including a critical lack of standardization across single-use designs and components from different manufacturers, complex supply chain dependencies with long lead times, and mounting plastic waste disposal issues under rising sustainability pressures.
The target customers for the single-use industry market primarily encompass biopharmaceutical and pharmaceutical companies, contract development and manufacturing organizations (CDMOs/CMOs), healthcare providers, hospitals, and outpatient clinics. These customers require scalable, highly productive, cost-efficient, and sterile manufacturing and clinical solutions to eliminate the risk of cross-contamination and accelerate time-to-market. Their preferences lean strongly toward flexible, modular single-use assemblies, single-patient disposable medical products, and sustainable or customizable solutions that bypass time-consuming cleaning validations. Purchasing behavior is heavily driven by stringent regulatory compliance, infection-prevention mandates, and operational efficiency, with a growing reliance on direct sales, group purchasing organization (GPO) contracts, and long-term supply agreements to ensure a reliable pipeline of critical consumables.
Market entry, expansion, and profitability in the single-use industry market are heavily shaped by evolving regulatory frameworks, rapid technological integration, and distinct economic pressures. Regulatory bodies like the FDA and EMA strictly govern the industry, mandating stringent validation processes for material compatibility, extractables, and leachables to ensure biological safety, which can lengthen approval cycles for new entrants. Technologically, the market is being disrupted by advancements in sensor accuracy, modular designs, automation, and the integration of smart single-use bioreactors that improve upstream consistency, process control, and scalability from clinical to commercial production. Economically, while high global demand for biologics, biosimilars, and personalized medicine ensures sustained growth, profitability is optimized by the significant cost-efficiency of single-use platforms—which cut facility capital costs by 25–30%, reduce turnaround times by up to 40%, and lower utility expenses through the omission of resource-intensive cleaning. However, long-term profitability faces restraints from high high-end manufacturing demands, environmental concerns regarding solid waste management, and supply chain vulnerabilities due to a reliance on a limited number of specialized component suppliers.
The single-use industry market is being rapidly reshaped by an accelerating shift toward automation, digitalization, and the widespread adoption of disposable technologies to optimize production efficiency and mitigate cross-contamination risks. Key emerging trends include the integration of digital monitoring and Internet of Things (IoT) solutions in single-use systems—with around 55% of manufacturers already implementing smart solutions—alongside a pronounced pivot toward sustainability initiatives focused on developing recyclable or lower-waste products. These trends are evolving swiftly, driven by surging global demand for mRNA vaccines, biologics, and cell and gene therapies, as highlighted by robust double-digit growth rates across various segments; for instance, the single-use system in biopharma manufacturing market is forecast to expand at a compound annual growth rate (CAGR) of 20.8% between 2026 and 2033, while the single-use assemblies market is projected to grow at a CAGR of 16.24% from 2025 to 2030, reflecting an aggressive industry transition toward highly flexible, scalable, and closed-system fluid pathways.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297
Technological innovations disrupting the single-use industry market are centered on increasing automation, digitization, and material integrity to support efficient and flexible biopharmaceutical manufacturing. Key advancements gaining significant traction include the integration of advanced single-use sensors, such as the BioPAT Viamass, which allow for real-time monitoring of critical parameters like viable cell density directly within disposable bioreactors to facilitate process analytical technology (PAT). Additionally, the development of high-capacity disposable platforms, exemplified by the introduction of 2000L microbial fermenters and 5L DynaDrive bioreactors, is expanding scalability and streamlining upstream cell culture workflows. The market is also being reshaped by the implementation of digital twin concepts, advanced container closure integrity strategies, and the integration of automation to minimize human error, alongside a material shift toward recyclable or lower-waste materials to improve sustainability.
In the single-use industry market, short-term trends are characterized by episodic demand fluctuations and temporary supply chain disruptions that trigger immediate pricing pressures and tactical adjustments for sponsors lacking long-term supply agreements. Conversely, long-term structural shifts are firmly anchored in permanent transformations toward flexible, scalable, and digitally integrated manufacturing infrastructure. These enduring evolutions include the widespread integration of automation, digitalization, and the broad adoption of single-use systems to enhance production efficiency and scalability, alongside a continuous transition from traditional batch processing to continuous bioprocessing lines.
Source:https://www.marketsandmarkets.com/Market-Reports/single-use-bioprocessing-market-231651297.html
